KRAS and neoplasm: Testing for KRAS mutations is possible from tumor DNA isolated from tumor tissue, bronchial brush smears, plasma or pleural fluid (cfDNA analysis), using either a single-gene PCR-based approaches, classical or a next-generation sequencing [98, 99].